Showing results (371-380 of 410) with videos related to
Sort By:
Pageof 41
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 22, 2022
Metal-Mediated Directional Capping of Rod-Packing Metal-Organic FrameworksAnh N Hong, Diana Luong, Mohammed Alghamdi, et al.Cancers|December 15, 2019
The α9 Nicotinic Acetylcholine Receptor Mediates Nicotine-Induced PD-L1 Expression and Regulates Melanoma Cell Proliferation and MigrationHai Duong Nguyen, You-Cheng Liao, Yuan-Soon Ho, et al.Journal of Food and Drug Analysis|June 13, 2022
Tea polyphenol epigallocatechin-3-gallate inhibits cell proliferation in a patient-derived triple-negative breast cancer xenograft mouse model via inhibition of proline-dehydrogenase-induced effectsWen-Jui Lee, Tzu-Chun Cheng, Yun Yen, et al.Journal of Food and Drug Analysis|June 1, 2022
Curcumin-induced antitumor effects on triple-negative breast cancer patient-derived xenograft tumor mice through inhibiting salt-induced kinase-3 proteinTzu-Chun Cheng, John Oliver Sayseng, Shih-Hsin Tu, et al.Talanta|December 10, 2021
LIFGO: A modular laser-induced fluorescence detection system based on plug-in blocksMeng-Ting Zhang, Ya-Mei Peng, Jian-Zhang Pan, et al.Research and Practice in Thrombosis and Haemostasis|March 20, 2023
BJTJ-1837, a novel FXI activation-blocking antibodyXugang He, Jin Zhang, Yanping Du, et al.Lab on a Chip|March 25, 2026
Digitally programmable microfluidic valving for autonomous, high-resolution continuous chromatographic purificationYi-Cheng Liao, Chih-Yi Huang, Yu-Chuan Tang, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|January 22, 2004
From D-glucose to biologically potent L-hexose derivatives: synthesis of alpha-L-iduronidase fluorogenic detector and the disaccharide moieties of bleomycin A2 and heparan sulfateJinq-Chyi Lee, Shu-Wen Chang, Chih-Cheng Liao, et al.Journal of Translational Medicine|March 9, 2023
Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patientsChih-Chin Hsu, Jong-Shyan Wang, Yu-Chiau Shyu, et al.Antibody Therapeutics|May 18, 2026
Development of SDP0505: a first-in-class HER3 × c-Met bispecific ADC, demonstrates potent antitumor activity in EGFR TKI-resistant NSCLC, CRC, and beyondLi-Min Wang, Changyong Yang, Simeng Chen, et al.Pageof 41